Abstract
Abstract: Several hundred publications in the years 2007 and 2008 elucidate the ongoing progress in pediatric liver transplantation. Compared with previous reviews (2005–2006 and 2006–2007), the trend of reducing the initial loss of patients and grafts is stabilized and reaches more than 90% one‐yr cumulative patient survival. Given this remarkable progress, the issue of QoL after pediatric liver transplantation becomes even more important and will be addressed with special emphasis. Long‐term side effects of calcineurin inhibitors, growth, food allergy, adherence, pregnancy, and sexual function will be discussed in this context. Apart from these topics, papers reporting new insights in immunosuppression and ways to achieve immunotolerance will be reviewed. New trends in setting the indication for liver transplantation in children will be referred. This review will only reflect these aspects of pediatric liver transplantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
